Latest news with #IonEndoluminalSystem
Yahoo
6 days ago
- Business
- Yahoo
UnityPoint Health – Trinity's new medical system helps detect lung cancer earlier
UnityPoint Health – Trinity is going small in order to make a big impact on lung cancer. Its new acquisition is called the Ion Endoluminal System, a robotic-assisted machine for minimally invasive biopsy in the lung. '(The system) uses an ultra-thin catheter, which has a diameter of 3.5 millimeters and a working channel of two millimeters,' said Dr. Abdul M. Rana, a UnityPoint Health – Trinity pulmonologist. 'It lets us go into more peripheries to help us diagnose lungs that may not have been previously (examined by) biopsy-using traditional platforms.' A deeper look into the lung means lung cancer can be detected earlier, which Rana said is critical. 'Five-year survival is about 90 percent versus someone who is diagnosed with a Stage 4 disease,' Rana said. 'At that point, you're looking at a survival rate of 10 to 20 percent.' The need for the newly acquired system is clear: Both Iowa and Illinois have higher rates of new lung cancer cases than the national average, according to the American Lung Association. 'This platform gives us the ability to do multiple lung nodules in different parts of the lung, so it's not like you have to come back and get another lung biopsy,' Rana said. The same-day procedure lasts about two hours, and results come back in three business days. 'With the software, we are able to virtually identify the target,' Rana said. The feedback has been positive so far. 'Most of the physicians are either trained on it, or getting trained on it, but we do feel like the numbers will increase, and we will be better able to serve our communities,' Rana said. According to the American Cancer Society, lung cancer is the leading cause of cancer-related deaths worldwide. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
27-05-2025
- Business
- Yahoo
30 years of Innovation and Impact: Dan Larson's Inspiring Story
Intuitive Patient Day L to R Abhishek Biswas, MD, Federico Barbagli, and Dan Larson view an Ion Endoluminal System Intuitive Patient Day Dan Larson at a da Vinci 5 console at Intuitive in Sunnyvale CA L to R Dan Larson and Baiya Krishnadasan, MD Dan Larson, Cindy Larson, and Dr. Abhishek Biswas tour Intuitive's facilities in Sunnyvale, CA. SUNNYVALE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- When Seattle resident Dan Larson was diagnosed with lung cancer in 2023, his only exposure to robotic technology was through his work as a quality engineer at Boeing. He could never have imagined that robotic technology made by Intuitive, the pioneer of robotic-assisted surgery, would one day play a pivotal role in his health care. Having experienced the loss of his father to lung cancer, Dan was determined to overcome his own diagnosis and enjoy his retirement with his family. Under the care of clinicians at MultiCare Tacoma General Hospital in Washington, Dan underwent two robotic lung biopsies with the Ion Endoluminal System, Intuitive's robotic-assisted bronchoscopy platform, followed by a robotic-assisted lobectomy—removal of part of the lung— with the da Vinci 5 system, Intuitive's next-generation multiport robotic system. Following his successful procedures, Intuitive invited Dan and his wife Cindy, and his physicians, Abhishek Biswas, MD and Baiya Krishnadasan, MD, FACS, both from Tacoma General, to join the engineers, manufacturers, and other Intuitive employees who designed the technology that helped change his life to share his story as the company marks 30 years since its founding. 'When you've seen a loved one go through what I saw my father go through, you're willing to do anything if it means you will get better. I was lucky to have experienced doctors with the best technology near me, and from New Year's Eve to today, it's been a great recovery,' said Dan. 'To other people who may think they're in a similar situation, don't wait to get checked, get your answers, and have it taken care of,' said Dan. Dan spent his career dedicated to quality as a quality assurance investigator at Boeing, so the opportunity to see a behind-the-scenes manufacturing tour at Intuitive was especially meaningful. He witnessed the precision and dedication that goes into building the Ion and da Vinci systems, the technologies used in his care. Dr. Abhishek Biswas, who performed Dan's two Ion biopsies - one that resulted in a diagnosis in 2023 and then to detect local recurrence in 2024 - demonstrated the system to Dan and showed him the 3D navigation path of his own lungs that Dr. Biswas used for guidance when navigating to his target lung nodule. 'Dan was one of the first 25 patients I was able to biopsy with Ion, and without it, his cancer could have progressed to stage four. This technology is truly transformative. Thank you to Intuitive for developing something that is uniquely different and that has made a huge impact on my work, so I can do what is right for my patient,' said Biswas, interventional pulmonologist at MultiCare. Once Dan's lung cancer had been diagnosed, Dr. Baiya Krishnadasan, cardiothoracic surgeon at MultiCare, used the da Vinci 5 system to remove part of his lung on New Year's Eve 2024. "Dan's case is truly heartwarming and special. This was a very complex procedure with a high risk of complications, but with the use of the da Vinci 5 system, we performed a successful operation, and he was able to return home within 48 hours. His positive attitude is inspiring, and it's gratifying to see how well he's done. I'm excited to teach others how to use this remarkable technology," said Krishnadasan. MultiCare Health System was one of the first health systems in the Pacific Northwest to install a da Vinci 5 system. MultiCare has 30 da Vinci systems across various sites, including four da Vinci 5's, as well as four Ion Endoluminal Systems. 'Dan's story is powerful evidence of Intuitive's 30-year mission of putting patients first,' said Intuitive President Dave Rosa. 'Each day at Intuitive, we strive to solve hard problems so that clinicians can provide better outcomes for their patients. It was an honor to have Dan, his wife Cindy, and his physicians meet our teams to reinforce the connection between our employees and the patients that are taken care of using our technology,' said Rosa. 2025 marks Intuitive's 30th year developing robotic-assisted technology with the goal of improving patient outcomes, improving patient and care team experience, increasing access to minimally invasive care, and lowering the total cost to treat. In Intuitive's first three decades, surgeons performed nearly 17 million da Vinci procedures, and nearly 90,000 surgeons have been trained to use Intuitive's systems. To mark Dan's visit, Intuitive employees united to complete an internal Impact Wellness Challenge in collaboration with the Intuitive Foundation, raising $25,000. This amount will be donated by the Intuitive Foundation to St. Jude Children's Research Hospital, a charity chosen by Dan and his wife Cindy. Contact: Peper Long, About Intuitive Intuitive (NASDAQ: ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most. About Ion Ion is Intuitive's robotic-assisted platform for minimally invasive biopsy in the lung. The system features an ultra-thin, ultra-maneuverable catheter that allows navigation far into the peripheral lung and provides the unprecedented stability necessary for precision in biopsy. About da Vinci Surgical Systems There are several models of the da Vinci Surgical System. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels, and forceps) that are designed to help with precise dissection and reconstruction deep inside the body. Important Safety Information Patients should talk to their doctor to decide if surgery with a da Vinci system is right for them. Patients and doctors should review all available information on nonsurgical and surgical options and associated risks in order to make an informed decision. Serious complications may occur in any surgery, including surgery with a da Vinci system, up to and including death. For important safety information, including surgical risks and considerations, please refer to For product intended use and/or indications for use, risks, cautions, and warnings and full prescribing information, refer to the associated user manual(s) or visit The demonstration of safety and effectiveness for the representative-specific procedures was based on evaluation of the da Vinci 5 system as a surgical tool and did not include evaluation of outcomes related to the treatment of cancer (overall survival, disease-free survival, local recurrence) or treatment of the patient's underlying disease or condition. Device usage in all surgical procedures should be guided by the clinical judgment of an adequately trained surgeon. Individuals' outcomes may depend on a number of factors—including but not limited to—patient characteristics, disease characteristics, and/or surgeon experience. Photos accompanying this announcement are available at: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12-03-2025
- Health
- Yahoo
Good Samaritan gets robotic help with lung biopsies
VINCENNES, Ind. (WTWO/WAWV)— Good Samaritan announced the acquisition of a new state-of-the-art robotic-assisted platform for minimally invasive lung biopsies. The name of this new platform is the Ion Endoluminal System. The technology will help with both precision and access while diagnosing lung nodules. This could then be used to detect and treat lung cancer earlier in patients. According to the news release, lung cancer is still the leading cause of cancer-related deaths, though early detection can significantly improve survival rates. This new system is made by the same group that created the da Vinci Surgical System. The system will allow doctors to navigate deep into the lungs of a patient with increased stability and precision. The system will also allow tissue sampling from hard-to-reach nodules with less invasive procedures. Good Sam reinstates mask requirements 'With the introduction of Ion, we can provide our patients with a more advanced and minimally invasive approach to lung biopsy,' said Good Samaritan Pulmonologist Johnathon Grant, DO. 'This means greater accuracy, faster results, and ultimately, better outcomes for those at risk of lung cancer.' The technology is said to be able to complete more successful biopsies with less complications. Patients can learn more about this new technology at this link. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
CBS News
25-02-2025
- Health
- CBS News
Allegheny Health Network using new robotic tool to diagnose lung cancer
As technology advances in the fight against cancer, Allegheny Health Network is using a new robotic tool to diagnose lung cancer. For many people doctor's visits bring anxiety, but the word cancer brings a whole new level of stress. Doctors told Jacqueline Rysz she might have lung cancer after they found one mass in her left lung and another mass in her right lung. "By this time, my heart is beating so fast, I'm thinking, 'Oh my God, I have cancer," Rysz said. "Everybody thought it was cancer." After seeing more doctors and having more scans done, she came to Allegheny Health Network Forbes Hospital for a second opinion. AHN Forbes Hospital Pulmonologist Dr. Giath Shari used new robot-assisted equipment to enter Rysz's lungs this time. With the tube in the main airway, doctors dropped an ultra-thin, extra-maneuverable catheter down to her lungs with a camera to see the lungs in real time. While inside the lungs, Dr. Shari drained one abscess and performed a biopsy on the other mass, and Rysz learned she was cancer-free. "I was like, 'Oh, my God.' I started crying because I was just really, really happy," Rysz said. With this Ion Endoluminal System, doctors said they could collect lung tissue samples for biopsy in a simpler way and get results quicker. "They don't have to wait until they recover from a surgical biopsy to start treatment for cancer," Doctor Shari said. It reaches small lesions in all 18 segments of the lung. "With a traditional scope, we could never go that far," said Dr. Hiran Fernando, the Director of Thoracic Surgery for AHN Forbes. Doctors said it's more precise and stable with fewer procedures. It can reduce risks for patients. "If we find lung cancers early, we have a much better chance of curing them," said Dr. Fernando. Rysz said she's relieved this procedure was a "one and done" situation. "With me, I have a lot of anxiety about this, to begin with, and I thought, 'Well if I have to go through this five or six times, it would be horrible.'" For Rysz, this medical experience is a wake-up call to be vigilant about her health. It's also a reminder for her that not being one of thousands of new cases of lung cancer comes down to the science and skill of doctors and technology. "If you have any signs of lung cancer, get this bronchoscopy, because it is simple, easy and it saves you a lot of trouble from having a lot of other tests done," said Rysz. "It was a miracle for me, a miracle."
Yahoo
12-02-2025
- Business
- Yahoo
Medical Robotics Market Size to Reach USD 63.84 Billion by 2032, at 16.19% CAGR
The Medical Robotics Market is expanding with demand for AI-driven surgical, rehabilitation, and service robots, enhancing precision, efficiency, and patient care. Austin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Medical Robotics Market Size & Growth Insights: According to the SNS Insider, 'The Medical Robotics Market Size was valued at USD 16.6 billion in 2023, is projected to reach USD 63.84 billion by 2032, growing at a CAGR of 16.19% from 2024 to 2032.' Emerging technologies are being adopted to drive growth and expansion of network infrastructure coupled with supportive regulatory frameworks and significant investment in robotics are some of the factors influencing growth. This is driving growth and applications in the medical sector. Get a Sample Report of Medical Robotics Market Forecast @ Leading Market Players with their Product Listed in this Report are: Intuitive Surgical, Inc. (da Vinci Surgical System, Ion Endoluminal System) Stryker Corporation (MAKO System, SpineAssist) Medtronic Plc (Hugo Surgical System, Mazor X Stealth Edition) Becton, Dickinson and Company (SmartSite Infusion Set, BD Pyxis MedStation) Omnicell, Inc. (Omnicell Robotics, OmniFlex Medication Dispensing Robot) Arxium (Arxium Automated Pharmacy, RIVA Pharmacy Automation) Asensus Surgical, Inc. (Senhance Surgical System, Aesculus 3D Visualization System) Zap Surgical Systems, Inc. (Zap-X Radiosurgery System, Zap-X Surgical Robot) Renishaw Plc (Neuroinspire, Renishaw Spine Robotics) Smith & Nephew Plc (RAS System, Navio Surgical System) Zimmer Biomet Holdings, Inc. (MOTION Platform, ROSA Knee System) DIH Holdings US Inc. (DIH Surgical Robot, DIH Modular Robotic Arm) Accuray Incorporated (CyberKnife, TomoTherapy) CMR Surgical (Versius Surgical System, Versius Robotic System) Ekso Bionics Holdings, Inc. (EksoGT, EksoHealth) Bionik Laboratories Corp. (ARKE Robotics, INNOVA System) Lifeward, Inc. (Lifeward Exoskeleton, Lifeward Robotic Arm) Cyberdyne Inc. (HAL Exoskeleton, Cybernic Treatment) Avateramedical Gmbh. (Avatera Surgical Robot, Avatera Robotic Surgery System) Johnson & Johnson (Verb Surgical System, Monarch Platform) Swisslog Healthcare (Swisslog Automated Dispensing, PillPick) Relay Robotics (Relay Robot, Relay Hybrid System) Aethon (TUG Autonomous Mobile Robot, Aethon Smart Logistics) Xenex Disinfection Services Inc. (Xenex LightStrike Robot, LightStrike Germ-Zapping Robot) Zoll Medical Corporation (ZOLL Robotic Assisted Cardiopulmonary Resuscitation, ZOLL Medical ECG Management). Medical Robotics Market Report Scope: Report Attributes Details Market Size in 2023 USD 16.6 Billion Market Size by 2032 USD 63.84 Billion CAGR CAGR of 16.19% From 2024 to 2032 Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook Key Segmentation • By Type (Surgical Robotic Systems, Rehabilitation Robotic Systems, Radiosurgery Robotic Systems, Hospital & Pharmacy Robotic Systems)• By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Pharmacies, Rehabilitation Centers, Other End Users) Key Drivers • Minimally Invasive Robotic-Assisted Surgeries Offer Faster Recovery, Reduced Risk, and Enhanced Precision, Driving Market Growth.• Technological Advancements in AI, Machine Learning, and Sensors Enhance Precision, Versatility, and Affordability of Medical Robotics. Do you Have any Specific Queries or Need any Customize Research on Medical Robotics Market, Request for Analyst Call @ By Type, Surgical Robotic Systems Dominating, Rehabilitation Robotic Systems Fastest Growing In 2023, the Surgical Robotic Systems segment led the medical robotics market, accounting for approximately 44% of the revenue. Fueled by the growing adoption of robotic-assisted surgeries across several surgical fields, including general surgery, orthopedics and gynecology, which provide advantages like improved precision, shorter recovery times and lower complication rates. Increasing investments from healthcare providers and manufacturers also amplify the growth of this segment. The Rehabilitation Robotic Systems segment is expected to grow at the fastest CAGR of 18.31% from 2024 to 2032, driven by rising prevalence of neurological and musculoskeletal disorders, an aging population, and advancements in AI and machine learning that enhance personalized therapy and recovery outcomes. By End User, Hospitals & Clinics Dominating, Ambulatory Surgery Centers Fastest Growing In 2023, the Hospitals & Clinics segment held the largest revenue share of approximately 45% in the medical robotics market. These categories are led by the rise of robotic systems consolidated well into the larch healthcare complexes resulting in accurate surgical measures, time-efficient recoveries, and positive results. Hospitals and clinics can afford this advanced robotics to perform an array of medical tasks. The Ambulatory Surgery Centers (ASCs) segment is projected to grow at the fastest CAGR of 18.70% from 2024 to 2032. By growing demand for minimally invasive, low-cost procedures in outpatient settings with ASCs implementing robotic systems to provide high-quality care while driving down the cost of operation and improving patient convenience. Purchase Single User PDF of Medical Robotics Market Report (33% Discount) @ Regional Analysis: North America Dominates, Asia Pacific Fastest Growing In 2023, North America led the medical robotics market, capturing around 41% of the revenue. The dominance is attributed to presence of the advanced healthcare infrastructure, high investments in robotic technologies, and high adoption of surgical and rehabilitation robotics in the region. The availability of major market players and government policies supportive of widespread reimbursement systems have also facilitated the adoption of medical robots in hospitals and clinics. The Asia Pacific region is expected to grow at the fastest CAGR of 18.08% from 2024 to 2032, driven by rising healthcare spend, increasing demand for minimally invasive procedures, rapid infrastructure upgrades, and government initiatives. The increasing geriatric population and burgeoning medical tourism in the region is also propelling the adoption of robotic systems for surgical and rehabilitation applications. Table of Contents - Major Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 5.1 Adoption Rates of Emerging Technologies 5.2 Network Infrastructure Expansion, by Region 5.3 Regulatory factors influencing growth 5.4 Investment and funding activities in robotics 6. Competitive Landscape 7. Medical Robotics Market Segmentation, by Type 8. Medical Robotics Market Segmentation, by End User 9. Regional Analysis 10. Company Profiles 11. Use Cases and Best Practices 12. Conclusion Access More Research Insights of Medical Robotics Market Growth & Outlook Report 2024-2032@ [For more information or need any customization research mail us at info@ About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)Sign in to access your portfolio
